- Home
- EXEL vs AOS Comparison
EXEL vs AOS Comparison
Compare EXEL & AOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- AOS
- Stock Information
- Founded
- EXEL 1994
- AOS 1874
- Country
- EXEL United States
- AOS United States
- Employees
- EXEL N/A
- AOS N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- AOS Industrial Machinery/Components
- Sector
- EXEL Health Care
- AOS Industrials
- Exchange
- EXEL Nasdaq
- AOS Nasdaq
- Market Cap
- EXEL 10.4B
- AOS 9.7B
- IPO Year
- EXEL 2000
- AOS N/A
- Fundamental
- Price
- EXEL $38.12
- AOS $65.70
- Analyst Decision
- EXEL Buy
- AOS Buy
- Analyst Count
- EXEL 23
- AOS 6
- Target Price
- EXEL $44.10
- AOS $78.00
- AVG Volume (30 Days)
- EXEL 3.0M
- AOS 1.4M
- Earning Date
- EXEL 11-04-2025
- AOS 10-28-2025
- Dividend Yield
- EXEL N/A
- AOS 2.19%
- EPS Growth
- EXEL 81.76
- AOS N/A
- EPS
- EXEL 2.08
- AOS 3.70
- Revenue
- EXEL $2,230,005,000.00
- AOS $3,830,100,000.00
- Revenue This Year
- EXEL $9.14
- AOS $2.77
- Revenue Next Year
- EXEL $12.51
- AOS $4.20
- P/E Ratio
- EXEL $18.32
- AOS $17.72
- Revenue Growth
- EXEL 10.73
- AOS N/A
- 52 Week Low
- EXEL $31.90
- AOS $58.83
- 52 Week High
- EXEL $49.62
- AOS $77.92
- Technical
- Relative Strength Index (RSI)
- EXEL 46.88
- AOS 33.47
- Support Level
- EXEL $33.76
- AOS $65.06
- Resistance Level
- EXEL $40.63
- AOS $67.30
- Average True Range (ATR)
- EXEL 1.31
- AOS 1.51
- MACD
- EXEL 0.07
- AOS -0.32
- Stochastic Oscillator
- EXEL 63.54
- AOS 10.90
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About AOS A.O. Smith Corporation
A.O. Smith manufactures a broad lineup of water heaters, boilers, and water treatment products. The company has two reporting segments: North America (75% of sales) and rest of world (25% of sales). A.O. Smith is the leading manufacturer of water heaters in North America for the residential and commercial markets, with approximately 37% and 54% market share, respectively. Residential water heaters account for most of North American sales and are distributed equally through wholesale and retail channels. Most of A.O. Smith's international revenue is from China, a market the company entered during the mid-1990s. However, the firm announced a strategic review of its China operations.